Skip to content
2000
Volume 22, Issue 1
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963375307250521100744
2025-05-23
2025-12-17
Loading full text...

Full text loading...

/deliver/fulltext/cpr/22/1/CPR-22-1-03.html?itemId=/content/journals/cpr/10.2174/0115733963375307250521100744&mimeType=html&fmt=ahah

References

  1. Galindo-ZavalaR. Bou-TorrentR. Magallares-LópezB. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.Pediatr. Rheumatol. Online J.20201812010.1186/s12969‑020‑0411‑9 32093703
    [Google Scholar]
  2. UzielY. ZifmanE. HashkesP.J. Osteoporosis in children: Pediatric and pediatric rheumatology perspective: A review.Pediatr. Rheumatol. Online J.2009711610.1186/1546‑0096‑7‑16 19835571
    [Google Scholar]
  3. CianciaS. van RijnR.R. HöglerW. Osteoporosis in children and adolescents: When to suspect and how to diagnose it.Eur. J. Pediatr.202218172549256110.1007/s00431‑022‑04455‑2 35384509
    [Google Scholar]
  4. BowlesSK Drug-induced osteoporosis.Women’s and men’s health2024Availabe from:https://www.accp.com/docs/bookstore/psap/p7b03.sample04.pdf
    [Google Scholar]
  5. MazziottiG. CanalisE. GiustinaA. Drug-induced osteoporosis: Mechanisms and clinical implications.Am. J. Med.20101231087788410.1016/j.amjmed.2010.02.028 20920685
    [Google Scholar]
  6. LeeW.J. SchumockG.T. LeeT.A. Drugs associated with adverse drug events in children: Analysis of the United States FDA adverse event reporting system database.Value Health2013163A7010.1016/j.jval.2013.03.311
    [Google Scholar]
  7. SridharanK. SivaramakrishnanG. Adverse event profile of first-line drugs for treating patent ductus arteriosus in neonates: A disproportionality analysis study of USFDA adverse event reporting system.Paediatr. Drugs202426676778510.1007/s40272‑024‑00657‑3 39367998
    [Google Scholar]
  8. WangY.H. WintzellV. LudvigssonJ.F. SvanströmH. PasternakB. Association between proton pump inhibitor use and risk of fracture in children.JAMA Pediatr.2020174654355110.1001/jamapediatrics.2020.0007 32176276
    [Google Scholar]
  9. TabaieS.A. O’MaraA.E. SheppardE.D. TosiL.L. A comprehensive review of bone health in a child: From birth to adulthood.J. Am. Acad. Orthop. Surg.202432936337210.5435/JAAOS‑D‑23‑00853 38261781
    [Google Scholar]
  10. WardL.M. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence.Front. Endocrinol. (Lausanne)202414126698610.3389/fendo.2023.1266986 38374961
    [Google Scholar]
/content/journals/cpr/10.2174/0115733963375307250521100744
Loading
/content/journals/cpr/10.2174/0115733963375307250521100744
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test